Sign In
to Comment, Vote &
Create Storyboards.
 
Terns Pharma broadens beyondTerns Pharmaceuticals Inc.'s stock jumped 7.5% premarket Tuesday, after the company announced positive data from an early-stage trial of a treatment for chronic myeloid leukemia.
1
0
0


Storyboard
Print
Share this Article



Comments


Please Sign In to comment


##username##
##datetime##
##comment##
##commentlikeno##Likes
##commentdislikeno##Dislikes